What's New on ResearchNet?
Table of Contents
- Electronic Approval Tool Pilot
- Implementation of Section 56 of the Controlled Drugs and Substances Act Requirements
- Addition of Gender and Sex Health Research (GSHR) Requirements
- Changes to Merit Reviews
- Peer Review Process Improvements
Electronic Approval Tool Pilot
June 22, 2011
The Electronic Approval Tool pilot continues on ResearchNet, and has been expanded to include the following CIHR programs.
The eApproval process allows Administrators to review and electronically approve applications for which the applicant has selected their institution. This means that for these programs your application will be routed through the authorized representative at the institution for electronic approval prior to it being sent to CIHR. The applicant must submit the application by the Institution Deadline Date which is an internal deadline date set by them and is clearly indicated on ResearchNet. Once the authorized representative reviews the application, they may return it to the applicant requesting that changes be made or they may electronically approve it and submit it to CIHR on the applicant's behalf. The applicant will be notified via email when their application has been received at CIHR.
The Funding Opportunities may have more program specific details regarding the Electronic Approval process. The complete list of programs using the Electronic Approval process is:
- Open Operating Grants
- Master's Awards
- Vanier Canada Graduate Scholarships
- Knowledge Synthesis Grant
- Partnerships for Health System Improvement (PHSI)
- Proof of Principle Program - Phase I
- Proof of Principle Program - Phase II
- Randomized Controlled Trials: Mentoring
- Catalyst Grant - CEEHRC Epigenetics, Environment & Health (added September 2011)
- CEEHRC Epigenomics Platform (added Septembre 2011)
- Collaborative Health Research Projects (NSERC partnered) (added June 2012)
Please refer to the policy "CIHR Policy on the Institutional Electronic Approval of Applications" for more information regarding the eApproval process.
If your program is not listed above, it is not yet using the Electronic Approval process.
Implementation of Section 56 of the Controlled Drugs and Substances Act Requirements
December 23, 2010
In an eAlert distributed in July 2010, it was announced that under Section 56 of the Controlled Drugs and Substances Act, applicants must obtain an exemption from Health Canada in order to conduct research involving the use of controlled drugs and substances. An exemption will be granted by Health Canada in cases where the Minister deems that the exemption is "necessary for a medical or scientific purpose or is otherwise in the public interest."
ResearchNet has been updated as of December 23, 2010 to implement the system aspect of this policy. Applicants can now self-identify when their applications will require them to seek an exemption from Health Canada under Section 56 of the Controlled Drugs and Substances Act.
If a funded application requires an exemption from the Act, funds will not be released until the Health Canada exemption has been provided to CIHR by the applicant. Applicants will be asked to upload the exemption letter received from Health Canada once the decision on funding has been announced to the applicant. Upon receipt of this letter, funding will be released. For CIHR's policy on pending grants and awards, consult the subsection titled "Pending Grants and Awards" in the CIHR Grants and Awards Guide.
Consult the Department of Justice website for details regarding Section 56 of the CDSA. Consult the Health Canada website for details regarding the process and requirements for obtaining an exemption under Section 56 of the CDSA.
Addition of Gender and Sex Health Research (GSHR) Requirements
December 23, 2010
As of December 23, 2010, all applicants will be required to respond to two questions on CIHR application forms about whether their research designs include gender and sex considerations. This requirement is in response to a Federal Health Portfolio Sex and Gender-Based Analysis (SGBA) Policy that requires the use of SGBA across all health portfolio activities including research, programs, and policies to address the different needs of women, men, girls and boys. This requirement is also in support of the Treasury Board of Canada's requirement of SGBA across all government. Information collected from applicants regarding gender and sex considerations in research designs will be used to provide updates to the Minister of Health, Office of the Auditor General, and Treasury Board.
For more information on how gender and/or sex might be integrated into your research designs, refer to Gender, Sex and Health Research Guide: A Tool for CIHR Applicants.
Changes to Merit Reviews
December 23, 2010
Changes have recently been made to the review fields for programs using Merit Review. Previously reviewers had been limited to a maximum of 4,000 characters when entering their merit reviews in ResearchNet. This limit has since been removed, eliminating the restriction placed on reviewers.
Peer Review Process Improvements
December 8, 2010
CIHR has made improvements to its peer review process on ResearchNet. Reviewers will now be able to update their own reviews once the Peer Review Committee meeting has ended. The day after the committee meeting ends, reviewers will have the ability to update their own reviews on ResearchNet for approximately five business days.